Our locations are open for all appointments and procedures, including COVID-19 testing. Schedule an appointment online or call your doctor’s office. Patients may now be accompanied by visitors. Read our updated visitor policy.

Skip to main content
NYU Langone Provider
NYU Langone providers are employed by NYU Langone Health as part of our physician network, known as the Faculty Group Practice.

Daniel H. Sterman, MD

NYU Langone Provider
NYU Langone providers are employed by NYU Langone Health as part of our physician network, known as the Faculty Group Practice.
  • Specialties: Pulmonary Medicine, Critical Care
  • Language: English
  • Phone: 212-731-6162
Request an Appointment

I chose to specialize in interventional pulmonology because it offers the opportunity to perform hands-on procedures that directly help patients, and it involves innovative research into new treatments for lung disease. Interventional pulmonology began to emerge as a medical specialty as I was finishing medical school, so I had the chance to work with pioneers who built the specialty into what it is today—a hybrid of pulmonary medicine and thoracic surgery, in which we perform minimally invasive procedures to diagnose and treat people with cancers of the chest.

I evaluate patients at NYU Langone Pulmonary and Critical Care Associates and Perlmutter Cancer Center, diagnosing and treating people who have lung cancer, malignant pleura mesothelioma—a rare cancer affecting the membranes lining the lungs—and pleural effusion, which is a buildup of fluid between those membranes. I diagnose and manage cancers and benign disorders affecting the large airways of the lungs: the trachea and bronchi. I also perform staging procedures to determine the degree of advancement of a person’s condition.

When someone first comes to my office, we sit down and have an in-depth discussion about his or her medical history. I talk to family members and friends to obtain detailed background information about my patient’s experiences. When I have this information, I use a physical exam, imaging tests, and discussions with other NYU Langone specialists to create a specific diagnostic, staging, or treatment plan.

This holistic and patient-centered approach to care is the foundation of all care at Perlmutter Cancer Center and NYU Langone Pulmonary and Critical Care Associates. When patients come to see me at Perlmutter Cancer Center, they can also visit with chemotherapy and radiation experts—thoracic medical oncologists and thoracic radiation oncologists, respectively—as well as thoracic surgeons, all in the same afternoon. We aim to make the visit as positive as possible, the procedures as safe as possible, and the treatments as easy as possible for every patient. 

We are also building on a long and historic track record of advancements in pulmonary and critical care medicine here at NYU Langone. In addition to offering a variety of chest services across the hospital, we participate in novel research and clinical trials. I have spent the last 18 years studying ways to use gene therapy and immunotherapy to control tumors of the chest, treat people with both lung cancer and malignant pleural mesothelioma, and improve and prolong the quality of patients’ lives.


Conditions and Treatments

Conditions
  • lung cancer
  • lung metastasis
  • pleural effusion
  • mesothelioma
  • tracheal stenosis
  • mediastinal disease
  • mediastinal tumor
  • neuroendocrine tumor of the lung
  • small cell lung cancer
  • mediastinal lymphadenopathy
  • solitary fibrous tumor
  • malignant mesothelioma
  • adenoid cystic carcinoma of the lung
  • thoracic cancer
  • coughing up blood
  • lung carcinoma
  • mucoepidermoid carcinoma of the lung
  • thymus cancer
  • non-small cell lung cancer
  • lung mass

Positions
Board Certifications
  • American Board of Internal Medicine (Pulmonary Disease), 1996
Education and Training
  • Fellowship, University of Pennsylania, Cardiovascular Research Group, Pulm & Critical Care, 1996
  • Fellowship, NA, 1996
  • Fellowship, NA, 1993
  • Residency, University of Pennsylania, Cardiovascular Research Group, Medicine, 1992
  • MD from Cornell University, 1989

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna International
    • Aetna Medicare Managed Care
    • Aetna Meritain Health
    • Aetna Open Access EPO
    • Aetna Open Access HMO
    • Aetna POS
    • Aetna POS (American Express Employer)
    • Aetna PPO
    • Aetna Signature Administrators PPO
    • Aetna Student Plan
    • Allied
    • Chesterfield Resources Inc
    • Christian Brothers Services
    • CoreSource
    • Healthscope
    • Nippon Life of America-Aetna
    • Nippon Life-Aetna
    • Starmark
    • WellNet
  • Amida Care
    • Amida Care Medicaid
  • Blue Cross Blue Shield
    • BCBS Blue Access EPO Large Group
    • BCBS Blue Access EPO Small Group
    • BCBS Blue Access GEPO Large Group
    • BCBS Blue Access GEPO Small Group
    • BCBS Blue Access HMO Small Group
    • BCBS Blue Access PPO Large Group
    • BCBS EPO
    • BCBS EPO (BlackRock Employees)
    • BCBS EPO (NYU Winthrop Employees)
    • BCBS EPO - Empire EPO (NYU Langone Employees)
    • BCBS EPO - Empire EPO (Sunset Park/Family Health Center Employees)
    • BCBS EPO - Empire NYU Care (NYU Langone Employees)
    • BCBS EPO - Empire NYU Care (NYU Winthrop Employees)
    • BCBS EPO - Empire NYU Care (Sunset Park/Family Health Center Employees)
    • BCBS Federal Program
    • BCBS HMO
    • BCBS Indemnity
    • BCBS Local 32BJ Employees
    • BCBS Mediblue Medicare HMO
    • BCBS Mediblue Medicare PPO
    • BCBS POS
    • BCBS PPO
    • BCBS PPO (BlackRock Employees)
    • BCBS PPO (NYU Winthrop Employees)
    • BCBS PPO - Empire PPO (Sunset Park/Family Health Center Employees)
    • BCBS PPO/EPO Small Group
    • New York Hotel Trades
  • Centerlight Healthcare
    • CenterLight Healthcare DIRECT
    • CenterLight Healthcare PACE
    • CenterLight Healthcare Select
    • Centerlight Pace Medicare HMO
  • Cigna
    • Apwu Health Plan
    • Cigna Great West PPO
    • Cigna HMO
    • Cigna Indemnity
    • Cigna Managed Care/POS
    • Cigna NALC
    • Cigna Open Access
    • Cigna Open Access PPO
    • Cigna PPO
    • Cigna Premier Plus
    • Consolidated Health Plans-NYU Student
    • Great West HMO
    • MVP-Cigna Network
  • Connecticare
    • Connecticare Commercial
  • Emblem
    • Emblem Select Care Basic Exchange
    • Emblem Select Care Bronze Exchange
    • Emblem Select Care Gold Exchange
    • Emblem Select Care Platinum Exchange
    • Emblem Select Care Silver Exchange
  • GHI
    • American Plan Administrators
    • GHI CBP (City of New York Employees)
    • GHI Emblem Health EPO
    • GHI Emblem Health PPO
    • GHI HMO
    • GHI HMO Medicare
    • GHI Medicare PPO
    • GHI Medicare Supplement
    • GHI Network Access - Benefit Services of PA
    • GHI Network Access - Total Plan Concepts
    • IUOE Local 14-14B
    • Wlny-TV Inc.
  • HIP
    • HIP Access I
    • HIP Access II
    • HIP Bridge
    • HIP Child Health Plus
    • HIP EPO
    • HIP HMO
    • HIP Medicare VIP
    • HIP POS
    • HIP Prime Bronze
    • HIP Prime Gold
    • HIP Prime Platinum
    • HIP Prime Silver
    • HIP VIP Medicare - VIP Go
    • HIP Vytra Healthcare Managed Care
  • Health Smart
    • WTC Health Program-HHC
  • Local 1199
    • Local 1199 - NYU Hospital Member Choice
    • Local 1199 PPO
  • Magnacare
    • Magnacare PPO
  • Medicare
    • Medicare Part B
  • Multiplan
    • AXA Assistance USA
    • Administrative Concepts
    • Beech Street PPO
    • Diversified Administration Corporation
    • Fiserv Health
    • GEHA
    • Global Excel
    • Global Health
    • Guardian Life Insurance Co Of America
    • Health Net Of California
    • Health Republic Of NJ
    • Humana Health Plan
    • Insurance Design Administrators
    • Kaiser Foundation
    • Kaiser Permanente
    • Meritain Health
    • Multiplan PPO
    • Multiplan-Capital Dist Phys Health
    • Mutual Of Omaha
    • Nippon Life Ins Co
    • PHCS
    • Professional Benefit Admin
    • Qualcare Inc
    • Screen Actors Guild
    • Teamsters Allied Benefits
    • US Life Insurance Company
  • NYSHIP - The Empire Plan
    • NYS Health Insurance Plan - The Empire Plan
  • Oxford
    • Oxford Health Plans Freedom
    • Oxford Health Plans Liberty
  • POMCO Insurance Company
    • POMCO Insurance Company
  • Qualcare Inc.
    • Qualcare Direct
  • Railroad Medicare
    • Palmetto GBA Railroad Medicare
  • Tricare
    • TRICARE
    • TriWest
    • US Family Health Plan
  • United Healthcare
    • AARP Medicare Complete
    • Oxford Health Plans Medicare Advantage
    • UMR
    • UMR WTC Health Program
    • United Healthcare AARP
    • United Healthcare Choice
    • United Healthcare Choice (AMEX employees)
    • United Healthcare Choice (Blackrock employees)
    • United Healthcare Choice (CBS employees)
    • United Healthcare Choice (Viacom Employees)
    • United Healthcare Choice NSLIJ
    • United Healthcare EPO
    • United Healthcare EPO (NYU Langone Health Employees)
    • United Healthcare HMO
    • United Healthcare Indemnity
    • United Healthcare Indemnity (NYU Langone Health Employees)
    • United Healthcare Medicare
    • United Healthcare Navigate
    • United Healthcare POS
    • United Healthcare PPO
    • United Healthcare Plus (NYU Langone Health Employees)
    • United Healthcare Student Resources
    • United Healthcare Value, Advantage and HDHP (New York University employees)
    • UnitedHealthcare Choice (JP Morgan Employees)
  • Veterans Choice
    • Veterans Choice Program-VACAA
View All Accepted Plans This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Locations and Appointments

NYU Medical Oncology Associates

160 East 34th Street, 8th Floor
New York, NY 10016

NYU Pulmonary & Critical Care Associates

530 1st Avenue, HCC, Suite 5D
New York, NY 10016

Interests

gene therapy, immunotherapy, tumor vaccines, thoracic malignancies

Research Summary

Dr. Sterman’s research interests are related to the treatment of thoracic malignancies, specifically as they apply to the synergy of molecular medicine and novel technologies in Interventional Pulmonology.  Over the past 17 years, he has focused on the translation of laboratory discoveries from the bench to the bedside: conducting Phase I human clinical trials of gene therapy and vaccine therapy for lung cancer, mesothelioma, and other pleural malignancies. Dr. Sterman is the lead clinical investigator in the multidisciplinary Thoracic Oncology Research Group at Penn and has been the Principal Investigator of Project 1 (Clinical Trials Project) for this NCI Program Project Grant since 1998. He is currently the sponsor and Principal Investigator of the ongoing Ad.IFN gene therapy trial aimed at patients with malignant pleural mesothelioma. Dr. Sterman and colleagues are developing trials involving delivery of the interferon-alpha gene via adenoviral vector in combination with standard chemotherapy, based upon success in pre-clinical studies, as well as with other immunomodulatory agents.  He is also a co-investigator on a clinical trial of intrapleural injection of a recombinant, replication-incompetent adenoviral viral vector expressing the HSV-TK gene with patients with malignant pleural effusions.  In addition, Dr. Sterman has also been involved in pioneering clinical research aimed at developing advanced bronchoscopic techniques to treat diseases such as severe asthma, emphysema and prolonged post-operative air leaks, as well as novel diagnostic and therapeutic approaches for peripheral lung cancers.  He is a prior president of the International Mesothelioma Interest Group and a former member of the scientific advisory board of the Mesothelioma Applied Research Foundation.

 

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *
represents one publication
Loading...
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

  • An Adaptive Phase 2/3 Randomized Double-Blind Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients with COVID-19

    Learn More
  • A Phase 3 Open-Label Randomized Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination with Celecoxib and Gemcitabine in Patients with Malignant Pleural Mesothelioma

    Learn More
View All Research Studies (2)

Read All Publications (107)

Related News